Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Placing Participation

3 Dec 2009 14:00

RNS Number : 5491D
Pantheon Leisure PLC
03 December 2009
 



Pantheon Leisure plc / Epic: PLEI / Market: AIM / Sector: Leisure

3 December 2009

Pantheon Leisure plc ('Pantheon' or 'the Company')

Placing Participation

The Board of Pantheon Leisure plc, the AIM quoted company formed to acquire businesses in the leisure sector, is pleased to announce that as part of a wider fundraising and capital reorganisation undertaken by ADDleisure plc ("ADDleisure") announced today, conditional on, inter alia, ADDleisure shareholder approval at a forthcoming ADDleisure general meeting to be held on 21 December 2009, the Company's short term loan to ADDleisure of £100,000 is to be repaid in full. In recognition of the provision of this loan, ADDleisure has agreed to grant to Pantheon an option over 100,000 new ordinary shares of 1 pence each in ADDleisure exerciseable at 10p per share ("ADDleisure Options"). The ADDleisure Options will be exerciseable at any time from the date of grant for a period of three years thereafter. 

In addition, the Directors believe that ADDleisure represents an attractive investment opportunity with its focus on Fitbug. Fitbug offers online personal health and well-being services by combining interactive tracking devices and web technology to measure activity and health indicators, provide feedback and motivate the user towards a healthier lifestyle. It is mainly focussed on the corporate wellness and health insurance sectors, with increasing effort being placed on the public health arena. Its blue-chip client base includes Nectar, PruHealth, BUPA, various Primary Care Trusts and Holmes Place Group. Fitbug also sells its products directly to individual consumers through its website, fitbug.com, as well as other retailers including Amazon and WH Smith. The Company is therefore subscribing for 1,000,000 new ADDleisure ordinary shares of 1p each at a placing price of 10p per share as part of ADDleisure's £1.2 million placing announced today.

The placing participation and the receipt of ADDleisure Options by Pantheon is a related party transaction within the meanings of the AIM Rules. Barbara Moss and Irvin Fishman, being the independent directors for the purpose of the placing participation, having consulted with Seymour Pierce Limited, the Company's Nominated Adviser, considers the terms of the placing fair and reasonable.

 

Commenting on the participation in the ADDleisure placing, Bill Weston, Chairman of Pantheon, said "We are delighted to be able to support ADDleisure which, through Fitbug, is focused on people's wellbeing through activity. This is something close to our heart with our Sport for School initiative as well as our small sided football leagues."

 

* * ENDS * *

For further information please visit www.pantheonleisure.com or contact:

Geoffrey Simmonds

Pantheon Leisure plc

Tel: 020 7935 0823

Mark Percy

Seymour Pierce Limited

Tel: 020 7107 8000

Isabel Crossley

St Brides Media & Finance Limited

Tel: 020 7236 1177

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUOOORKNRURAA
Date   Source Headline
23rd Apr 20247:00 amRNSCancellation - Bidstack Group PLC
22nd Mar 20241:11 pmRNSAppointment of Administrators & Nomad Resignation
11th Mar 20247:30 amRNSSuspension - Bidstack Group PLC
11th Mar 20247:00 amRNSIntention to Appoint Administrators & Suspension
5th Feb 20247:00 amRNSUpdate on CLN, Financial Update & Strategic Review
22nd Dec 20237:00 amRNSSettlement & new commercial partnership - Azerion
1st Nov 20237:00 amRNSChange of Registered Office
18th Oct 20233:45 pmRNSProposed CLN, Share Reorganisation and VST Update
29th Sep 20237:00 amRNSBoard Change
29th Sep 20237:00 amRNSProposed New Commercial Partnership
29th Sep 20237:00 amRNSInterim Results
30th Aug 20237:00 amRNSVenatus Advertising Sales Partnership
23rd Aug 20234:47 pmRNSTR-1: Notification of Major Holdings
21st Jul 202311:23 amRNS2023 Annual General Meeting Results
18th Jul 202311:46 amRNSGeneral Meeting Requisition Request withdrawn
18th Jul 20237:00 amRNSBoard Changes
13th Jul 20231:32 pmRNSVirtual stadium partnership with first NFL team
11th Jul 20237:00 amRNSRequisitioned General Meeting
5th Jul 20237:00 amRNSRequest to requisition a General Meeting
21st Jun 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
20th Jun 20238:18 amRNSFinal Results and Annual Report - replacement
20th Jun 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
1st Mar 20235:28 pmRNSComment on Azerion Statement
15th Feb 20237:00 amRNSBidstack appoints Thomas Bullen as CFO
13th Feb 20232:05 pmRNSSecond Price Monitoring Extn
13th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20237:00 amRNSTrading and Operational Update
18th Jan 202311:22 amRNSChange of Registered Office
3rd Jan 202311:05 amRNSSecond Price Monitoring Extn
3rd Jan 202311:00 amRNSPrice Monitoring Extension
3rd Jan 20237:00 amRNSAzerion Update
29th Dec 20227:00 amRNSBoard Changes
9th Dec 202211:04 amRNSGrant of LTIP Options
8th Dec 20227:00 amRNSExercise of Options, Issue of Equity & TVR
6th Dec 202211:03 amRNSTR-1: Notification of major holdings
5th Dec 20227:00 amRNSBidstack adds 2 titles with a AAA game publisher
1st Nov 20223:39 pmRNSTR-1: Notification of major holdings
31st Oct 20223:35 pmRNSTotal Voting Rights
31st Oct 20223:21 pmRNSTR-1: Notification of major holdings
31st Oct 20222:16 pmRNSTR-1: Notification of major holdings
31st Oct 202211:54 amRNSTR-1: Notification of major holdings
28th Oct 20224:16 pmRNSTR-1: Notification of Major Holdings
28th Oct 20227:00 amRNSUpdate re Press Commentary
26th Oct 20223:45 pmRNSAdmission of Ordinary Shares and TVR
26th Oct 20227:00 amRNSStrategy Update
25th Oct 202212:08 pmRNSResults of General Meeting
13th Oct 20227:00 amRNSBidstack appoints Camila Franklin as COO
6th Oct 20226:28 pmRNSResults of REX Retail Offer
6th Oct 20228:06 amRNSResults of Placing and Subscription
5th Oct 20224:36 pmRNSREX Retail Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.